population
Dialysis Patient
A dialysis patient is a person receiving dialysis, a population for whom supplement information may need to be considered in context. This page focuses on options relevant to this group rather than defining a symptom, diagnosis, or treatment.
A focused overview for the Dialysis Patient population, bringing relevant supplement information into one place.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 not enough evidence
Strength TrainingpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
Open the Strength Training page
May not suit people with this condition
Supplements and practices linked to problems for people with this condition.
Coffee EnemapracticeUnclear
People receiving dialysis have tightly managed fluid and electrolyte balance, so unmonitored losses from Coffee Enema may be particularly hazardous.
Open the Coffee Enema pageFinnish SaunapracticeUnclear
Sweating-related fluid and electrolyte shifts may lead to low blood pressure and high potassium in people receiving dialysis.
Open the Finnish Sauna page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesStrength TrainingCertaintyLowSourceRCT
Pooled analyses whose designs were not recorded found that exercise in people undergoing dialysis reduced IL-6 (SMD −0.46), TNF-α (SMD −0.67) and CRP (SMD −0.50), and increased IL-10 (SMD 0.63).
Who was studied
- People with a condition
Open Strength TrainingStudy result
Subgroup analyses showed exercise significantly reduced IL-6 (SMD −0.46), TNF-α (SMD −0.67), and CRP (SMD −0.50) and increased IL-10 (SMD 0.63) in patients undergoing dialysis.
What to avoid
Interventions recorded as making it worse2 listedHighest probability
- →PracticesCoffee EnemaCertaintyLowSourceReference knowledge
People receiving dialysis have tightly managed fluid and electrolyte balance, so unmonitored losses from Coffee Enema may be particularly hazardous.
Open Coffee EnemaRationale
Dialysis patients have tightly managed fluid and electrolyte balance, making unmonitored enema-related losses particularly hazardous.
- →PracticesFinnish SaunaCertaintyLowSourceTheoretical
Sweating-related fluid and electrolyte shifts may lead to low blood pressure and high potassium in people receiving dialysis.
Open Finnish SaunaRationale
Fluid and electrolyte shifts from sweating can cause hypotension and hyperkalemia in dialysis patients.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
A dialysis patient is a person receiving dialysis, a population for whom supplement information may need to be considered in context. This page focuses on options relevant to this group rather than defining a symptom, diagnosis, or treatment. Findings may apply only to particular dialysis populations, so they should not automatically be generalized to everyone receiving dialysis.
Evidence-backed options
L-Carnitine has been studied in elderly hemodialyzed patients, where supplementation was associated with changes in amino acid metabolism, fatty acid metabolism, blood acyl-carnitine levels, and energy production. These findings describe metabolic measures rather than establishing improvement in symptoms, dialysis outcomes, or overall health.
The available description does not specify the amount taken, how long supplementation continued, or how quickly any changes appeared. It also does not establish whether the findings apply to all people receiving dialysis, including those of different ages or with different health circumstances. The option is therefore best understood as a metabolic finding from a specific dialysis population, rather than a complete treatment conclusion. Anyone considering options related to dialysis should discuss them with a clinician familiar with their care.
What to avoid
For people receiving dialysis, Beetroot Extract is flagged because it is high in potassium and oxalates. Dialysis involves restricted potassium intake, while renal failure impairs oxalate clearance; together, these factors can increase the risk of hyperkalemia and oxalate accumulation.
Taurine and Vitamin C raise related concerns involving impaired renal handling. Renal failure markedly impairs normal taurine disposition, and repeated supplementation in dialysis patients has produced extreme hypertaurinemia with neurologic symptoms such as severe dizziness and vertigo. High-dose or prolonged Vitamin C can also lead to systemic oxalate accumulation and oxalosis because oxalate clearance is impaired. Routine Vitamin C replacement doses may still be used under nephrology supervision, while any consideration of Taurine is best discussed with a nephrology clinician.
Coffee Enema is flagged because dialysis patients have tightly managed fluid and electrolyte balance. Unmonitored enema-related losses may therefore be particularly hazardous, even though the concern is not based on the same potassium or oxalate mechanism as Beetroot Extract and Vitamin C.
Finnish Sauna is flagged for review rather than as a verified restriction. No mechanism is recorded for this contraindication, so its relevance to dialysis patients remains uncertain. A clinician familiar with the person’s dialysis treatment can help interpret whether it is appropriate in an individual case.